EE186 A Comparative Cost Analysis between Dalbavancin, Oritavancin and Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain
Abstract
Authors
M. Rios D. Carcedo J. Sabaniego I. Rossellò